The revenue of Royalty Pharma plc over the past 8 years
Chart Royalty Pharma plc: revenue, fiscal 2018–2025 Open the chart →Royalty Pharma plc reported revenue of $2.38B in fiscal 2025, the latest fiscal year on file. In fiscal 2018 it was $1.79B — up 32% over 7 years. Year over year, revenue rose 5 times and fell twice. The largest one-year move was in fiscal 2020: up 17%, from $1.81B to $2.12B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $2.38B |
| 2024ended Dec 31, 2024 | $2.26B |
| 2023ended Dec 31, 2023 | $2.35B |
| 2022ended Dec 31, 2022 | $2.24B |
| 2021ended Dec 31, 2021 | $2.29B |
| 2020ended Dec 31, 2020 | $2.12B |
| 2019ended Dec 31, 2019 | $1.81B |
| 2018ended Dec 31, 2018 | $1.79B |
Fiscal years as Royalty Pharma plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Royalty Pharma plc
- The profitability of Royalty Pharma plc
- The debt of Royalty Pharma plc
- All of Royalty Pharma plc's financials, charted
Companies of a similar size
- UIUBIQUITI INC.
- ACGLARCH CAPITAL GROUP LTD.
- CBOECboe Global Markets, Inc.
- EXPEEXPEDIA GROUP, INC.
- CCLCarnival Corp Ltd.
Not investment advice. This page shows what Royalty Pharma plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.